|2005N-0345|| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product|
|FDA Comment Number :||EC740|
|Submitter :||Mrs. Jeanine Loh||Date & Time:||10/13/2005 08:10:33|
|Organization :||Mrs. Jeanine Loh|
|Category :||Individual Consumer|
| This drug will weaken the health of women. Please protect us! It will only increase suffering by giving people a false sense of freedom that will only ensnare them later. (see below).
Research from the UK also revealed that over the counter access to Plan B "coincides with surges in STD rates. In areas where a limited program began in 1999 . . . chlamydia cases rose from 7,000 in 1999 to 10,000 cases in 2002. Gonorrhea cases climbed nearly 50 percent, to nearly 3,000 cases in 2002 . . . Abortions increased by nearly 6,000 in a one year period, jumping 3.2 percent in 2003 from 2002, with the largest leap among girls under the age of 16."